Furthermore, we have demonstrated that Nrf2-dependent HO-1 induction prevents neuroblastoma cell death after GSH depletion or bortezomib treatment and HO-1 inhibition or silencing restore cell sensitivity [77,90,91]. This evidence concerns the gene HMOX1 and neuroblastoma.